To assess the distinct characteristics of EZH2 with other PRC2 components in breast cancer, the expression levels of PRC2 components (EZH2, SUZ12, EED, EZH1, RBBP4, and RBBP7) were evaluated using TCGA datasets. Here, EZH1 is linked to breast carcinoma.